Peptide Purity by HPLC vs Mass Spectrometry: What Each Proves

HPLC and mass spectrometry answer different questions. HPLC measures how much of a sample is your target peptide — purity. Mass spectrometry confirms the molecule is the one named on the label — identity. Neither substitutes for the other.

That distinction is why a research-grade certificate of analysis carries both as separate line items. A vial can be 99.1% one substance and still contain the wrong substance. A vial can contain exactly the right molecule and still be half something else. This note walks through what each method physically measures, what it reports, what it cannot see, and how to check both fields on the paperwork that ships with a reference standard.

The two questions a COA has to answer

A COA has to answer two independent questions about a lot: what fraction of this material is the target peptide, and is that target peptide the correct molecule. Purity answers the first. Identity answers the second.

The two questions are independent because they interrogate different physical properties. Chromatographic purity depends on how strongly a species interacts with a stationary phase. Mass confirmation depends on the molecule's atomic composition. Two species can share a retention time and differ in mass. Two species can share a mass and differ in retention time.

Methods that probe independent properties are called orthogonal. Orthogonality is the whole argument for running both: an error that is invisible to one method is usually visible to the other. When a supplier reports only one number, you have half a characterization and no way to know which half is missing.

What HPLC proves: purity by area percent

HPLC proves purity — the proportion of the injected sample that elutes as your target peak, expressed as a percentage. It does not establish what any peak actually is.

How the separation works

Peptide purity is run by reversed-phase HPLC (RP-HPLC), almost always on a C18-bonded silica column. The mobile phase is a water/acetonitrile gradient with roughly 0.1% trifluoroacetic acid (TFA) as an ion-pairing modifier. TFA suppresses residual silanol interactions and sharpens peak shape.

The vocabulary that method is written in — retention time, resolution, symmetry factor, system suitability — is defined compendially in USP General Chapter ⟨621⟩ Chromatography, the harmonized text shared by USP, the European Pharmacopoeia, and the Japanese Pharmacopoeia. When a COA names a column and a wavelength, that chapter is the standard its numbers are checkable against.

Species separate by hydrophobicity. The more hydrophobic the molecule, the longer it is retained, and the later it elutes. The target peptide emerges at a characteristic retention time under a fixed column, gradient, and flow rate. Change any of those and the retention time changes — which is why retention time alone is never an identity claim.

Detection is by UV absorbance. 214 nm is the standard peptide wavelength because the amide bond of the peptide backbone absorbs strongly in the far-UV (roughly 190–230 nm). Every residue contributes signal at 214 nm. A second channel at 280 nm detects only aromatic side chains — tryptophan, tyrosine, and phenylalanine — so it is blind to any sequence lacking them.

How area-percent purity is calculated

Purity by HPLC is area normalization:

target peak area ÷ total integrated peak area × 100

That is the number printed as "Purity ≥ 98.0% by RP-HPLC, UV 214 nm." Read the qualifier carefully. A ≥ value is a lower bound the supplier will stand behind. A specific value such as 99.2% is the measured integration for that lot. The word "typical" is not a lot-level claim at all — see how to read a certificate of analysis, field by field for what each qualifier commits the supplier to, and how to read an HPLC chromatogram — peaks, retention time, and area-percent for what the trace behind the number should look like.

What HPLC cannot tell you

HPLC cannot identify a peak. A peak at the expected retention time may be a different molecule that happens to share hydrophobicity with your target. Two species that co-elute integrate as a single peak and inflate the reported area percent. Species that do not absorb UV at the detection wavelength — many salts and counter-ions — are not counted at all.

So a 99% area-percent value means 99% of the UV-absorbing, chromatographically resolved material is one peak. It does not mean that peak is your peptide.

What mass spectrometry proves: identity by mass

Mass spectrometry proves identity — that the mass of the main component matches the theoretical mass calculated from the expected sequence. It is not a reliable purity measurement.

ESI-MS for peptides

Electrospray ionization (ESI) is the workhorse for peptide identity. Its compendial framing sits in USP General Chapter ⟨736⟩ Mass Spectrometry, with the applied guidance — ionization choice, resolution, and what a mass measurement can and cannot support — in ⟨1736⟩ Applications of Mass Spectrometry. ESI is a soft ionization method: it moves intact molecules into the gas phase as multiply-charged ions rather than fragmenting them. A peptide of mass M appears at a series of m/z values described by:

m/z = (M + n × 1.00728) ÷ n

where n is the charge state. Software deconvolutes that charge envelope back to a single molecular weight. MALDI-TOF is the common alternative, usually preferred for larger peptides and proteins, and it tends to produce singly-charged ions.

Here is what a theoretical mass looks like for a real reference standard — the 15-residue peptide sold as the BPC-157 reference standard:

That last row is a useful worked detail. The sequence contains no aromatic residues, so it absorbs weakly at 280 nm. Detection at 214 nm is not a stylistic choice for this molecule — it is the only wavelength that sees the whole backbone.

Reading the identity line

A COA states either an observed m/z, a deconvoluted molecular weight, or the phrase "ESI-MS: consistent with expected mass." The strongest documents give the observed value and the theoretical value side by side so you can check the difference yourself.

Note which mass is being quoted. High-resolution instruments (Q-TOF, Orbitrap) resolve the monoisotopic mass, calculated from the most abundant isotope of each element. Unit-resolution instruments report near the average mass, weighted across natural isotope abundance. For the example above those differ by about 0.84 Da — enough to look like a mismatch if you compare the wrong pair.

High-resolution MS is also what flags small structural changes. Deamidation of asparagine or glutamine shifts mass by about +0.984 Da. Oxidation, typically of methionine, shifts it by about +15.995 Da. A unit-resolution instrument cannot resolve a 0.98 Da shift on a 1419 Da molecule; a high-resolution instrument can.

Both shifts are small enough that the analytical literature approaches them as a separation problem as much as a mass problem. Badgett, Boyes, and Orlando, writing in the Journal of the American Society for Mass Spectrometry, separate and quantify methionine-oxidized and asparagine-deamidated peptide forms by coupling HILIC to MS precisely because the modified and unmodified species are otherwise hard to tell apart. That is the same orthogonality argument, one level down.

What mass spectrometry cannot tell you

MS is a poor purity measurement on its own. Ionization efficiency varies widely between species, so peak intensity in a mass spectrum is not proportional to molar abundance. A species that ionizes poorly can be under-represented or effectively invisible next to one that ionizes well.

That means a clean-looking mass spectrum is not evidence of a clean sample. MS confirms the main component is the right molecule. It does not tell you what fraction of the vial that component represents.

Why reference-grade characterization needs both

Reference-grade characterization reports HPLC purity and MS identity because each method catches the failure the other misses. Run one alone and you leave a specific, nameable gap.

HPLC only. You get a single dominant peak at 99.2% area. You do not know that the peak is your peptide. A deletion sequence, a truncation, or an unrelated hydrophobic species can occupy the expected retention window. Co-elution can hide a second species inside the main peak. The chromatogram looks clean and the material is not what the label says.

MS only. You confirm the expected mass to within 0.01 Da. You do not know how much of the vial that mass represents. A large fraction of the material can be a different-mass species that ionized poorly and never showed up. Right molecule, unknown purity.

Both, usually as LC-MS. Coupling the chromatograph to the mass spectrometer separates the sample first, then masses each resolved peak. The main peak is quantified by area normalization and mass-confirmed in the same run, and impurity peaks get provisional mass assignments instead of staying anonymous.

One more number sits outside both methods. Neither HPLC purity nor MS identity tells you how much peptide is in the vial by weight — lyophilized material carries residual water, TFA counter-ions, and salts. That figure comes from amino acid analysis (AAA) or elemental analysis, and it is why purity is not the same as net peptide content. AAA has its own compendial procedure — USP General Chapter ⟨1052⟩ Biotechnology-Derived Articles—Amino Acid Analysis, harmonized through the Pharmacopeial Discussion Group. Three questions, three methods, three separate line items.

How to check both on a COA

Checking both takes four passes over the document. Each one is a yes/no against a field that either names a method or does not.

1. Purity field names a method and a detector. "Purity ≥ 98.0% by RP-HPLC, UV 214 nm" is checkable. A bare "HPLC" with no wavelength is not. The characteristics an analytical procedure has to demonstrate before its numbers mean anything — specificity, accuracy, precision, detection and quantitation limits, range — are enumerated in ICH Q2(R2), Validation of Analytical Procedures and in USP ⟨1225⟩ Validation of Compendial Procedures.
2. Purity value has a qualifier you understand. A measured value or an explicit lower bound. "Typical" is a catalog claim, not a lot claim.
3. Identity field reports a mass, not an impression. Observed m/z or deconvoluted mass against the theoretical value, with the ionization mode named (ESI, MALDI). "Identity by visual inspection" is not identity — see COA red flags: a missing method or "identity by visual inspection".
4. Both fields carry the same lot number as your vial. A purity number from one lot and an identity confirmation from another describe no single material.

elev8 Labs COAs report purity by RP-HPLC with the detection wavelength named, and identity by ESI-MS, against the lot number printed on the vial. Both are retrievable by lot.

The short version

HPLC answers how much. Mass spectrometry answers which molecule. They probe independent properties, so a reference-grade COA reports both, tied to one lot number. If you want the full field-by-field walkthrough, start with what "reference-grade" actually means on a peptide label, or browse lot-level certificates of analysis.

Frequently asked questions

Does HPLC or mass spectrometry measure peptide purity?

HPLC measures purity. It reports the target peak's area as a percentage of the total integrated peak area, typically as "≥ 98.0% by RP-HPLC, UV 214 nm." Mass spectrometry confirms identity — which molecule the main component is — but is not reliably quantitative for purity, because ionization efficiency differs between species.

Why does a research peptide need both HPLC and mass spectrometry?

Because the two methods are orthogonal: they measure independent physical properties, so each catches what the other misses. HPLC tells you what fraction of the sample is your target peak but cannot identify that peak. Mass spectrometry confirms the molecule is correct but cannot quantify it. A reference-grade COA reports both.

What does ESI-MS confirm on a peptide COA?

Electrospray ionization mass spectrometry confirms molecular identity by comparing the observed mass against the theoretical mass of the expected sequence. A COA states an observed m/z, a deconvoluted molecular weight, or "ESI-MS: consistent with expected mass." The strongest documents print observed and theoretical values side by side so the difference is checkable.

What is area-percent purity?

Area-percent purity, also called area normalization, is the target peptide's peak area divided by the total integrated peak area, multiplied by 100. It is the number reported as, for example, "Purity ≥ 98.0% by RP-HPLC, UV 214 nm." It counts only species that separate chromatographically and absorb UV at the detection wavelength.

Can mass spectrometry alone prove a peptide is high-purity?

No. Mass spectrometry confirms the main component's identity, but peak intensity in a mass spectrum is not proportional to molar abundance — a poorly-ionizing impurity can be under-represented or invisible. Purity comes from HPLC area normalization. Identity comes from MS. Reported together, usually as LC-MS, they cover both questions.

Why is HPLC detection done at 214 nm for peptides?

The amide bond of the peptide backbone absorbs strongly in the far-UV, roughly 190–230 nm, so 214 nm gives signal from every residue in the sequence. Detection at 280 nm only sees aromatic side chains — tryptophan, tyrosine, and phenylalanine — which many peptide sequences lack entirely.

What is the difference between monoisotopic and average mass on a COA?

Monoisotopic mass is calculated from the most abundant isotope of each element; average mass is weighted across natural isotope abundance. High-resolution instruments (Q-TOF, Orbitrap) report monoisotopic values; unit-resolution instruments report near the average. For a 1419 Da peptide the two differ by roughly 0.84 Da, so compare like with like.

---

elev8 Labs products are reference standards for laboratory research only. Not for human consumption.